Core Viewpoint - Guangdong Zhongsheng Pharmaceutical Co., Ltd. has announced the provision of guarantees for its subsidiaries to support their operational financing needs, with a total guarantee amount not exceeding RMB 2 billion [1][2]. Summary by Sections Guarantee Overview - The company approved a guarantee amounting to a total of RMB 2 billion for its subsidiaries to enhance operational efficiency and ensure sustainable development [1]. - The chairman is authorized to implement related matters within the approved limit [1]. Specific Guarantees - The company’s wholly-owned subsidiary, Guangdong Zhongsheng Pharmaceutical Trading Co., Ltd., received a guarantee of RMB 100 million from the company for a credit facility with China Bank [2]. - Another subsidiary, Yunnan Yikang Pharmaceutical Co., Ltd., received a guarantee of RMB 10 million for a credit facility with China Merchants Bank [2]. Financial Metrics - Prior to the new guarantees, the company had a guarantee balance of RMB 950 million for Guangdong Zhongsheng Pharmaceutical Trading and RMB 20 million for Yunnan Yikang Pharmaceutical [2]. - After the new guarantees, the balances increased to RMB 1.05 billion and RMB 30 million, respectively [2]. Subsidiary Information - Guangdong Zhongsheng Pharmaceutical Trading Co., Ltd. was established on January 2, 2004, with a registered capital of RMB 50 million [3]. - Yunnan Yikang Pharmaceutical Co., Ltd. was established on March 15, 2007, also with a registered capital of RMB 50 million [5]. Guarantee Agreements - The company signed a maximum guarantee contract with China Bank on December 1, 2025, for a guarantee of up to RMB 100 million, valid for three years [6]. - A similar irrevocable guarantee was signed with China Merchants Bank for up to RMB 10 million, also valid for three years [6]. Board Approval - The guarantee matters were approved by the company’s board and the annual general meeting [7]. Total Guarantee Amount - As of the announcement date, the total guarantee amount provided by the company is RMB 1.486 billion, which accounts for 37.96% of the company's audited net assets as of December 31, 2024 [8]. - The guarantees include RMB 400 million for Guangdong Huanan Pharmaceutical Group, RMB 1.05 billion for Guangdong Zhongsheng Pharmaceutical Trading, and RMB 30 million for Yunnan Yikang Pharmaceutical [8]. Legal Standing - The company has not experienced any overdue guarantees or legal issues related to its guarantees [9].
广东众生药业股份有限公司关于公司为子公司提供担保的进展公告